A pilot study of oxidative pathways in MS fatigue: randomized trial of N‐acetyl cysteine-Reference-Cited by-同舟云学术

A pilot study of oxidative pathways in MS fatigue: randomized trial of N‐acetyl cysteine

Published:2021-03-06 Issue:4 Volume:8 Page:811-824
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann. Clin. Transl. Neurol.

Author:

Krysko Kristen M.¹²^ORCID,Bischof Antje¹^ORCID,Nourbakhsh Bardia³^ORCID,Henry Roland G.¹,Revirajan Nisha¹,Manguinao Michael¹,Nguyen Khang¹,Akula Amit¹,Li Yan⁴,Waubant Emmanuelle¹^ORCID

Affiliation:

1. UCSF Weill Institute for Neurosciences Department of Neurology University of California San Francisco San Francisco CaliforniaUSA

2. Division of Neurology Department of Medicine St. Michael’s HospitalLi Ka Shing Knowledge InstituteUniversity of Toronto Toronto Ontario Canada

3. Department of Neurology Johns Hopkins University Baltimore MarylandUSA

4. Department of Radiology and Biomedical Imaging University of California San Francisco San Francisco California USA

Funder

GE Healthcare

National Multiple Sclerosis Society

Race to Erase MS

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51325

Reference55 articles.

1. Fatigue associated with multiple sclerosis: diagnosis, impact and management

2. Quality of life in patients with multiple sclerosis

3. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study

4. Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment

5. Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing—remitting multiple sclerosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Stress and Symptoms Associated with Multiple Sclerosis.;2024-06-14

2. Iron in multiple sclerosis – Neuropathology, immunology, and real-world considerations;Multiple Sclerosis and Related Disorders;2023-10

3. N-Acetyl Cysteine as a Neuroprotective Agent in Progressive Multiple Sclerosis (NACPMS) trial: Study protocol for a randomized, double-blind, placebo-controlled add-on phase 2 trial;Contemporary Clinical Trials;2022-11

4. Variation of genes encoding nitric oxide synthases and antioxidant enzymes as potential risks of multiple sclerosis development: a preliminary study;Scientific Reports;2022-06-22

5. New drugs for multiple sclerosis: new treatment algorithms;Current Opinion in Neurology;2022-06